Expression of tissue factor pathway inhibitor-2 in murine and human liver regulation during inflammation

Summary

Tissue factor pathway inhibitor-2 (TFPI-2) is a recently described serine proteinase inhibitor. Human and murine TFPI-2 share about 50% homology. The aim of this study was to investigate the cellular localization of human and murine TFPI-2 in the liver and the regulation of their expression during acute inflammation. Northern blot, in situ hybridization and studies on isolated hepatocytes demonstrated a high-level expression of TFPI-2 in murine hepatocytes. On the other hand, very little TFPI-2 mRNA expression could be detected in human liver. Studies with isolated human liver cells suggested that TFPI-2 expression in human liver was mainly observed in liver sinusoidal endothelial cells rather than hepatocytes. Liver murine TFPI-2 expression was greatly increased after lipopolysaccharide administration with a delayed kinetics as compared to α1-acid glycoprotein, a classical acute-phase reactant. Accordingly, studies with isolated cells showed that the increase in TFPI-2 transcripts occurred in non-hepatocytic cells. Moreover, the LPS response was abolished in mice with a hepatocyte-specific KO for the gp130 receptor, thus indicating that a mediator from hepatocytes is involved in the up-regulation of TFPI-2 in non-parenchymal cells. In conclusion, murine TFPI-2 is highly expressed in hepatocytes in the normal murine liver and is upregulated in non-parenchymal cells in the context of inflammation. The large difference in the level of liver expression of human and murine TFPI-2 suggests that despite significant sequence similarities, these proteins presumably have different functions in the two species.

Keywords

Extracellular matrix - inflammatory mediators - proteases/ inhibitors - tissue factor pathway inhibitor (TFPI)

• References

• 1 Kisiel W, Sprecher CA, Foster DC. Evidence that a second human tissue factor pathway inhibitor (TFPI-2) and human placental protein 5 are equivalent. Blood 1994; 84: 4384-5.
• 2 Petersen LC, Sprecher CA, Foster DC. et al. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Biochemistry 1996; 35: 266-72.
• 3 Miyagi Y, Yasumitsu H, Mizushima H. et al. Cloning of the cDNA encoding mouse PP5/TFPI-2 and mapping of the gene to chromosome 6. DNA Cell Biol 1996; 15: 947-54.
• 4 Sprecher CA, Kisiel W, Mathewes S. et al. Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. Proc Natl Acad Sci USA 1994; 91: 3353-7.
• 5 Streetz KL, Wustefeld T, Klein C. et al. Lack of gp130 expression in hepatocytes promotes liver injury. Gastroenterology 2003; 125: 532-43.
• 6 Betz UA, Bloch W, van den Broek M. et al. Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects. J Exp Med 1998; 188: 1955-65.
• 7 Kellendonk C, Opherk C, Anlag K. et al. Hepatocyte-specific expression of Cre recombinase. Genesis 2000; 26: 151-3.
• 8 Klaunig JE, Goldblatt PJ, Hinton DE. et al. Mouse liver cell culture. I. Hepatocyte isolation. In Vitro 1981; 17: 913-25.
• 9 Ferrini JB, Pichard L, Domergue J. et al. Long-term primary cultures of adult human hepatocytes. Chem Biol Interact 1997; 107: 31-45.
• 10 Lalor PF, Edwards S, McNab G. et al. Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells. J Immunol 2002; 169: 983-92.
• 11 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
• 12 Puissant C, Houdebine LM. An improvement of the single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Biotechniques 1990; 08: 148-9.
• 13 Fort P, Marty L, Piechaczyk M. et al. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 1985; 13: 1431-42.
• 14 Kaabache T, Barraud B, Feldmann G. et al. Direct solution hybridization of guanidine thiocyanate-solubilized cells for quantitation of mRNAs in hepatocytes. Anal Biochem 1995; 232: 225-30.
• 15 Blazejewski S, Le Bail B, Boussarie L. et al. Osteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts. Am J Pathol 1997; 151: 651-7.
• 16 Faouzi S, Le Bail B, Neaud V. et al. Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study. J Hepatol 1999; 30: 275-84.
• 17 Neaud V, Hisaka T, Monvoisin A. et al. Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells. J Biol Chem 2000; 275: 35565-9.
• 18 Neaud V, Gillibert JDuplantier, Mazzocco C. et al. Thrombin upregulates tissue factor pathway inhibitor-2 synthesis through a cyclooxygenase-2-dependent, EGF receptorindependent, mechanism. J Biol Chem. 2003 in press.
• 19 Streetz KL, Wustefeld T, Klein C. et al. Mediators of inflammation and acute phase response in the liver. Cell Mol Biol (Noisyle-grand) 2001; 47: 661-73.
• 20 Nieto N, Dominguez-Rosales JA, Fontana L. et al. Rat hepatic stellate cells contribute to the acute-phase response with increased expression of alpha1(I) and alpha1(IV) collagens, tissue inhibitor of metalloproteinase-1, and matrix-metalloproteinase-2 messenger RNAs. Hepatology 2001; 33: 597-607.
• 21 Iino M, Foster DC, Kisiel W. Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2. Arterioscler Thromb Vasc Biol 1998; 18: 40-6.
• 22 Aldeguer X, Debonera F, Shaked A. et al. Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. Hepatology 2002; 35: 40-8.
• 23 Omori N, Evarts RP, Omori M. et al. Expression of leukemia inhibitory factor and its receptor during liver regeneration in the adult rat. Lab Invest 1996; 75: 15-24.
• 24 Bustos M, Beraza N, Lasarte JJ. et al. Protection against liver damage by cardiotrophin-1: a hepatocyte survival factor up-regulated in the regenerating liver in rats. Gastroenterology 2003; 125: 192-201.
• 25 Miyagi Y, Koshikawa N, Yasumitsu H. et al. cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2. J Biochem (Tokyo) 1994; 116: 939-42.
• 26 Izumi H, Takahashi C, Oh J. et al. Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes. FEBS Lett 2000; 481: 31-6.
• 27 Crawley JT, Goulding DA, Ferreira V. et al. Expression and localization of tissue factor pathway inhibitor-2 in normal and atherosclerotic human vessels. Arterioscler Thromb Vasc Biol 2002; 22: 218-24.
• 28 Kamei S, Petersen LC, Sprecher CA. et al. Inhibitory properties of human recombinant Arg24→Gln type-2 tissue factor pathway inhibitor (R24Q TFPI-2). Thromb Res 1999; 94: 147-52.
• 29 Hisaka T, Kisiel W, Rosenbaum J. cDNA cloning and tissue distribution of the rat ortholog of tissue factor pathway inhibitor-2. Thromb Haemost 2002; 88: 356-7.
• 30 Shimokawa T, Yamamoto K, Kojima T. et al. Down-regulation of murine tissue factor pathway inhibitor mRNA by endotoxin and tumor necrosis factor-alpha In vitro and In vivo. Thromb Res 2000; 100: 211-21.
• 31 Enkhbaatar P, Okajima K, Murakami K. et al. Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide- induced pulmonary vascular injury by inhibiting leukocyte activation. Am J Respir Crit Care Med 2000; 162: 1752-9.
• 32 Kazama Y, Kamei S, Kuijper JL. et al. Nucleotide sequence of the gene encoding murine tissue factor pathway inhibitor-2. Thromb Haemost 2000; 83: 141-7.
• 33 Petit L, Lesnik P, Dachet C. et al. The promoter of human tissue factor pathway inhibitor gene: identification of potential regulatory elements. Thromb Res 1999; 95: 255-62.